Preoperative frailty affects postoperative complications, exercise capacity, and home discharge rates after surgical and transcatheter aortic valve replacement
Assessment of frailty is important for risk stratification among the elderly with severe aortic stenosis (AS) when considering interventions such as surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). However, evidence of the impact of preoperative frailty on s...
Saved in:
Published in | Heart and vessels Vol. 36; no. 8; pp. 1234 - 1245 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Tokyo
Springer Japan
01.08.2021
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 0910-8327 1615-2573 1615-2573 |
DOI | 10.1007/s00380-021-01793-3 |
Cover
Loading…
Abstract | Assessment of frailty is important for risk stratification among the elderly with severe aortic stenosis (AS) when considering interventions such as surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). However, evidence of the impact of preoperative frailty on short-term postoperative outcomes or functional recovery is limited. This retrospective study included 234 consecutive patients with severe AS who underwent SAVR or TAVR at Kobe University Hospital between Dec 2013 and Dec 2019. Primary outcomes were postoperative complications, postoperative 6-min walking distance (6MWD), and home discharge rates. The mean age was 82 ± 6.6 years. There were 169 (SAVR: 80, TAVR: 89) and 65 (SAVR: 20, TAVR: 45) patients in the non-frail and frail groups, respectively (
p
= 0.02). The postoperative complication rates in the frail group were significantly higher than those in the non-frail group [30.8% (SAVR: 35.0%, TAVR: 28.9%) vs. 10.7% (SAVR: 15.0%, TAVR: 6.7%),
p
< 0.001]. The home discharge rate in the non-frail group was significantly higher than that in the frail group [85.2% (SAVR: 81.2%, TAVR: 88.8%) vs. 49.2% (SAVR: 55.0%, TAVR: 46.7%),
p
< 0.001]. The postoperative 6MWD in the non-frail group was significantly longer than that in the frail group [299.3 ± 87.8 m (SAVR: 321.9 ± 90.8 m, TAVR: 281.1 ± 81.3 m) vs. 141.9 ± 92.4 m (SAVR: 167.8 ± 92.5 m, TAVR: 131.6 ± 91.3 m),
p
< 0.001]. The TAVR group did not show a decrease in the 6MWD after intervention, regardless of frailty. We report for the first time that preoperative frailty was strongly associated with postoperative complications, 6MWD, and home discharge rates following both SAVR and TAVR. Preoperative frailty assessment may provide useful indications for planning better individualized therapeutic interventions and supporting comprehensive intensive care before and after interventions. |
---|---|
AbstractList | Assessment of frailty is important for risk stratification among the elderly with severe aortic stenosis (AS) when considering interventions such as surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). However, evidence of the impact of preoperative frailty on short-term postoperative outcomes or functional recovery is limited. This retrospective study included 234 consecutive patients with severe AS who underwent SAVR or TAVR at Kobe University Hospital between Dec 2013 and Dec 2019. Primary outcomes were postoperative complications, postoperative 6-min walking distance (6MWD), and home discharge rates. The mean age was 82 ± 6.6 years. There were 169 (SAVR: 80, TAVR: 89) and 65 (SAVR: 20, TAVR: 45) patients in the non-frail and frail groups, respectively (p = 0.02). The postoperative complication rates in the frail group were significantly higher than those in the non-frail group [30.8% (SAVR: 35.0%, TAVR: 28.9%) vs. 10.7% (SAVR: 15.0%, TAVR: 6.7%), p < 0.001]. The home discharge rate in the non-frail group was significantly higher than that in the frail group [85.2% (SAVR: 81.2%, TAVR: 88.8%) vs. 49.2% (SAVR: 55.0%, TAVR: 46.7%), p < 0.001]. The postoperative 6MWD in the non-frail group was significantly longer than that in the frail group [299.3 ± 87.8 m (SAVR: 321.9 ± 90.8 m, TAVR: 281.1 ± 81.3 m) vs. 141.9 ± 92.4 m (SAVR: 167.8 ± 92.5 m, TAVR: 131.6 ± 91.3 m), p < 0.001]. The TAVR group did not show a decrease in the 6MWD after intervention, regardless of frailty. We report for the first time that preoperative frailty was strongly associated with postoperative complications, 6MWD, and home discharge rates following both SAVR and TAVR. Preoperative frailty assessment may provide useful indications for planning better individualized therapeutic interventions and supporting comprehensive intensive care before and after interventions. Assessment of frailty is important for risk stratification among the elderly with severe aortic stenosis (AS) when considering interventions such as surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). However, evidence of the impact of preoperative frailty on short-term postoperative outcomes or functional recovery is limited. This retrospective study included 234 consecutive patients with severe AS who underwent SAVR or TAVR at Kobe University Hospital between Dec 2013 and Dec 2019. Primary outcomes were postoperative complications, postoperative 6-min walking distance (6MWD), and home discharge rates. The mean age was 82 ± 6.6 years. There were 169 (SAVR: 80, TAVR: 89) and 65 (SAVR: 20, TAVR: 45) patients in the non-frail and frail groups, respectively ( p = 0.02). The postoperative complication rates in the frail group were significantly higher than those in the non-frail group [30.8% (SAVR: 35.0%, TAVR: 28.9%) vs. 10.7% (SAVR: 15.0%, TAVR: 6.7%), p < 0.001]. The home discharge rate in the non-frail group was significantly higher than that in the frail group [85.2% (SAVR: 81.2%, TAVR: 88.8%) vs. 49.2% (SAVR: 55.0%, TAVR: 46.7%), p < 0.001]. The postoperative 6MWD in the non-frail group was significantly longer than that in the frail group [299.3 ± 87.8 m (SAVR: 321.9 ± 90.8 m, TAVR: 281.1 ± 81.3 m) vs. 141.9 ± 92.4 m (SAVR: 167.8 ± 92.5 m, TAVR: 131.6 ± 91.3 m), p < 0.001]. The TAVR group did not show a decrease in the 6MWD after intervention, regardless of frailty. We report for the first time that preoperative frailty was strongly associated with postoperative complications, 6MWD, and home discharge rates following both SAVR and TAVR. Preoperative frailty assessment may provide useful indications for planning better individualized therapeutic interventions and supporting comprehensive intensive care before and after interventions. Assessment of frailty is important for risk stratification among the elderly with severe aortic stenosis (AS) when considering interventions such as surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). However, evidence of the impact of preoperative frailty on short-term postoperative outcomes or functional recovery is limited. This retrospective study included 234 consecutive patients with severe AS who underwent SAVR or TAVR at Kobe University Hospital between Dec 2013 and Dec 2019. Primary outcomes were postoperative complications, postoperative 6-min walking distance (6MWD), and home discharge rates. The mean age was 82 ± 6.6 years. There were 169 (SAVR: 80, TAVR: 89) and 65 (SAVR: 20, TAVR: 45) patients in the non-frail and frail groups, respectively (p = 0.02). The postoperative complication rates in the frail group were significantly higher than those in the non-frail group [30.8% (SAVR: 35.0%, TAVR: 28.9%) vs. 10.7% (SAVR: 15.0%, TAVR: 6.7%), p < 0.001]. The home discharge rate in the non-frail group was significantly higher than that in the frail group [85.2% (SAVR: 81.2%, TAVR: 88.8%) vs. 49.2% (SAVR: 55.0%, TAVR: 46.7%), p < 0.001]. The postoperative 6MWD in the non-frail group was significantly longer than that in the frail group [299.3 ± 87.8 m (SAVR: 321.9 ± 90.8 m, TAVR: 281.1 ± 81.3 m) vs. 141.9 ± 92.4 m (SAVR: 167.8 ± 92.5 m, TAVR: 131.6 ± 91.3 m), p < 0.001]. The TAVR group did not show a decrease in the 6MWD after intervention, regardless of frailty. We report for the first time that preoperative frailty was strongly associated with postoperative complications, 6MWD, and home discharge rates following both SAVR and TAVR. Preoperative frailty assessment may provide useful indications for planning better individualized therapeutic interventions and supporting comprehensive intensive care before and after interventions.Assessment of frailty is important for risk stratification among the elderly with severe aortic stenosis (AS) when considering interventions such as surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). However, evidence of the impact of preoperative frailty on short-term postoperative outcomes or functional recovery is limited. This retrospective study included 234 consecutive patients with severe AS who underwent SAVR or TAVR at Kobe University Hospital between Dec 2013 and Dec 2019. Primary outcomes were postoperative complications, postoperative 6-min walking distance (6MWD), and home discharge rates. The mean age was 82 ± 6.6 years. There were 169 (SAVR: 80, TAVR: 89) and 65 (SAVR: 20, TAVR: 45) patients in the non-frail and frail groups, respectively (p = 0.02). The postoperative complication rates in the frail group were significantly higher than those in the non-frail group [30.8% (SAVR: 35.0%, TAVR: 28.9%) vs. 10.7% (SAVR: 15.0%, TAVR: 6.7%), p < 0.001]. The home discharge rate in the non-frail group was significantly higher than that in the frail group [85.2% (SAVR: 81.2%, TAVR: 88.8%) vs. 49.2% (SAVR: 55.0%, TAVR: 46.7%), p < 0.001]. The postoperative 6MWD in the non-frail group was significantly longer than that in the frail group [299.3 ± 87.8 m (SAVR: 321.9 ± 90.8 m, TAVR: 281.1 ± 81.3 m) vs. 141.9 ± 92.4 m (SAVR: 167.8 ± 92.5 m, TAVR: 131.6 ± 91.3 m), p < 0.001]. The TAVR group did not show a decrease in the 6MWD after intervention, regardless of frailty. We report for the first time that preoperative frailty was strongly associated with postoperative complications, 6MWD, and home discharge rates following both SAVR and TAVR. Preoperative frailty assessment may provide useful indications for planning better individualized therapeutic interventions and supporting comprehensive intensive care before and after interventions. Assessment of frailty is important for risk stratification among the elderly with severe aortic stenosis (AS) when considering interventions such as surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). However, evidence of the impact of preoperative frailty on short-term postoperative outcomes or functional recovery is limited. This retrospective study included 234 consecutive patients with severe AS who underwent SAVR or TAVR at Kobe University Hospital between Dec 2013 and Dec 2019. Primary outcomes were postoperative complications, postoperative 6-min walking distance (6MWD), and home discharge rates. The mean age was 82 ± 6.6 years. There were 169 (SAVR: 80, TAVR: 89) and 65 (SAVR: 20, TAVR: 45) patients in the non-frail and frail groups, respectively (p = 0.02). The postoperative complication rates in the frail group were significantly higher than those in the non-frail group [30.8% (SAVR: 35.0%, TAVR: 28.9%) vs. 10.7% (SAVR: 15.0%, TAVR: 6.7%), p < 0.001]. The home discharge rate in the non-frail group was significantly higher than that in the frail group [85.2% (SAVR: 81.2%, TAVR: 88.8%) vs. 49.2% (SAVR: 55.0%, TAVR: 46.7%), p < 0.001]. The postoperative 6MWD in the non-frail group was significantly longer than that in the frail group [299.3 ± 87.8 m (SAVR: 321.9 ± 90.8 m, TAVR: 281.1 ± 81.3 m) vs. 141.9 ± 92.4 m (SAVR: 167.8 ± 92.5 m, TAVR: 131.6 ± 91.3 m), p < 0.001]. The TAVR group did not show a decrease in the 6MWD after intervention, regardless of frailty. We report for the first time that preoperative frailty was strongly associated with postoperative complications, 6MWD, and home discharge rates following both SAVR and TAVR. Preoperative frailty assessment may provide useful indications for planning better individualized therapeutic interventions and supporting comprehensive intensive care before and after interventions. |
Author | Inoue, Takeshi Kawamori, Hiroyuki Yoshida, Naofumi Satomi-Kobayashi, Seimi Tsuboi, Yasunori Wakida, Kumiko Yamanaka, Katsuhiro Ogawa, Masato Yamashita, Tomoya Komaki, Kodai Toba, Takayoshi Hirata, Ken-ichi Otake, Hiromasa Omura, Atsushi Okada, Kenji Izawa, Kazuhiro P. Sakai, Yoshitada |
Author_xml | – sequence: 1 givenname: Kodai surname: Komaki fullname: Komaki, Kodai organization: Division of Rehabilitation Medicine, Kobe University Hospital – sequence: 2 givenname: Naofumi surname: Yoshida fullname: Yoshida, Naofumi organization: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine – sequence: 3 givenname: Seimi surname: Satomi-Kobayashi fullname: Satomi-Kobayashi, Seimi email: seimik@med.kobe-u.ac.jp organization: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine – sequence: 4 givenname: Yasunori surname: Tsuboi fullname: Tsuboi, Yasunori organization: Division of Rehabilitation Medicine, Kobe University Hospital – sequence: 5 givenname: Masato surname: Ogawa fullname: Ogawa, Masato organization: Division of Rehabilitation Medicine, Kobe University Hospital, Department of Public Health, Kobe University Graduate School of Health Sciences – sequence: 6 givenname: Kumiko surname: Wakida fullname: Wakida, Kumiko organization: Department of Nutrition, Kobe University Hospital – sequence: 7 givenname: Takayoshi surname: Toba fullname: Toba, Takayoshi organization: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine – sequence: 8 givenname: Hiroyuki surname: Kawamori fullname: Kawamori, Hiroyuki organization: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine – sequence: 9 givenname: Hiromasa surname: Otake fullname: Otake, Hiromasa organization: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine – sequence: 10 givenname: Atsushi surname: Omura fullname: Omura, Atsushi organization: Division of Cardiovascular Surgery, Department of Surgery, Kobe University Graduate School of Medicine – sequence: 11 givenname: Katsuhiro surname: Yamanaka fullname: Yamanaka, Katsuhiro organization: Division of Cardiovascular Surgery, Department of Surgery, Kobe University Graduate School of Medicine – sequence: 12 givenname: Takeshi surname: Inoue fullname: Inoue, Takeshi organization: Division of Cardiovascular Surgery, Department of Surgery, Kobe University Graduate School of Medicine – sequence: 13 givenname: Tomoya surname: Yamashita fullname: Yamashita, Tomoya organization: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine – sequence: 14 givenname: Yoshitada surname: Sakai fullname: Sakai, Yoshitada organization: Division of Rehabilitation Medicine, Kobe University Graduate School of Medicine – sequence: 15 givenname: Kazuhiro P. surname: Izawa fullname: Izawa, Kazuhiro P. organization: Department of Public Health, Kobe University Graduate School of Health Sciences – sequence: 16 givenname: Kenji surname: Okada fullname: Okada, Kenji organization: Division of Cardiovascular Surgery, Department of Surgery, Kobe University Graduate School of Medicine – sequence: 17 givenname: Ken-ichi surname: Hirata fullname: Hirata, Ken-ichi organization: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33615425$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UsFu1DAQtVAR3S78AAcUiQuHBsZ2EtsXpKpqAakSHOBseZ3JbqrEDrazYr-GX8W721LooSfLM--9Gfu9M3LivENCXlN4TwHEhwjAJZTAaAlUKF7yZ2RBG1qXrBb8hCxAUSglZ-KUnMV4C0BrRdULcsp5RlWsXpDf3wL6CYNJ_RaLLph-SLvCdB3aFIvJx_TQtX6cht7mi3fxvMBfGGwfc91MxvZpd14Y1xYbP2LR9tFuTFhjkbkYs2DCUMQ5rDN_OOBSMC5msQ3uW8aH1Ntia4Y8KOA0GIsjuvSSPO_MEPHV3bkkP66vvl9-Lm--fvpyeXFT2gZkKnkruFyJBhioSrSqFbapDa6g4apSEiRVTNlcZpbJTljB2o4awbFTTBha8SX5eNSd5tWIrc2jgxn0FPrRhJ32ptf_d1y_0Wu_1UIqUdM6C7y7Ewj-54wx6TH_AQ6DcejnqFmlGJOg6j307SPorZ-Dy8_TrK6k4sAryKg3_270d5V77zJAHgE2-BgDdjqbcDAn7W3UFPQ-JvoYE51jog8xyQpLwh5R79WfJPEjKWawW2N4WPsJ1h8PbtNz |
CitedBy_id | crossref_primary_10_1007_s00380_022_02143_7 crossref_primary_10_3389_fcvm_2023_1164104 crossref_primary_10_1016_j_amjcard_2024_04_001 crossref_primary_10_1253_circrep_CR_24_0020 crossref_primary_10_3390_jcdd10040142 crossref_primary_10_1016_j_arr_2024_102266 crossref_primary_10_1111_jgs_18454 crossref_primary_10_1016_j_urolonc_2023_07_003 crossref_primary_10_2169_internalmedicine_3146_23 |
Cites_doi | 10.1016/j.ijcard.2012.09.079 10.1161/CIR.0000000000000503 10.1111/j.1751-7133.2010.00151.x 10.1056/NEJMoa1008232 10.1093/ehjqcco/qcw001 10.1016/j.athoracsur.2018.03.003 10.1186/s12933-017-0577-8 10.1093/ejcts/ezs043 10.1177/2047487316679527 10.1371/journal.pone.0190359 10.1161/CIRCULATIONAHA.113.007477 10.1080/14017431.2019.1644366 10.1016/S0195-668X(03)00201-X 10.1016/j.cjca.2018.11.035 10.5551/jat.19737 10.1016/j.jtcvs.2019.11.069 10.1093/eurheartj/ehx391 10.2459/JCM.0000000000000494 10.1186/cc5713 10.1016/j.ahj.2016.12.005 10.1177/2047487313494029 10.1016/j.jacc.2016.12.006 10.1136/bmjopen-2018-024163 10.1002/ccd.27083 10.1056/NEJMoa1514616 10.1186/s13019-017-0655-8 10.4103/rcm.rcm_22_17 10.1038/nrdp.2016.6 10.1016/j.jacc.2017.06.024 10.1016/j.amjcard.2016.03.044 10.1016/j.athoracsur.2018.03.002 10.1016/j.ijcard.2014.03.121 10.1001/jamanetworkopen.2019.8398 10.1093/gerona/56.3.M146 10.1155/2018/9849475 10.1111/j.1076-7460.2007.06457.x 10.1002/ehf2.12052 10.1016/j.ajic.2004.10.008 |
ContentType | Journal Article |
Copyright | Springer Japan KK, part of Springer Nature 2021 Copyright Springer Nature B.V. 2021 |
Copyright_xml | – notice: Springer Japan KK, part of Springer Nature 2021 – notice: Copyright Springer Nature B.V. 2021 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 8FD FR3 K9. NAPCQ P64 7X8 5PM |
DOI | 10.1007/s00380-021-01793-3 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1615-2573 |
EndPage | 1245 |
ExternalDocumentID | PMC7897515 33615425 10_1007_s00380_021_01793_3 |
Genre | Journal Article |
GroupedDBID | --- -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 1SB 203 28- 29I 29~ 2J2 2JN 2JY 2KG 2LR 2P1 2VQ 2~H 30V 36B 3O- 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 7X7 88E 8AO 8FI 8FJ 8G5 8TC 8UJ 95- 95. 95~ 96X AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBRH ABBXA ABDBE ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHHG ADHIR ADHKG ADIMF ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFDZB AFEXP AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHPBZ AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AYFIA AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ7 GQ8 GRRUI GUQSH GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M2O M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P9S PF0 PHGZT PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 ZGI ZMTXR ZOVNA ZXP ~A9 ~EX AAYXX ABFSG ABRTQ ACSTC AEZWR AFHIU AFOHR AHWEU AIXLP ATHPR CITATION PHGZM PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7QO 8FD FR3 K9. NAPCQ P64 7X8 5PM |
ID | FETCH-LOGICAL-c608t-3d738b76020947d9d7c65aeb0639498081929c9d72c28f7c72df1a73ef927a143 |
IEDL.DBID | U2A |
ISSN | 0910-8327 1615-2573 |
IngestDate | Thu Aug 21 18:33:46 EDT 2025 Fri Sep 05 00:18:09 EDT 2025 Wed Sep 03 00:17:12 EDT 2025 Mon Jul 21 05:47:04 EDT 2025 Tue Aug 05 12:12:23 EDT 2025 Thu Apr 24 23:09:40 EDT 2025 Thu Apr 10 07:46:46 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Aortic stenosis Frailty Surgical aortic valve replacement Exercise capacity Transcatheter aortic valve replacement |
Language | English |
License | This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c608t-3d738b76020947d9d7c65aeb0639498081929c9d72c28f7c72df1a73ef927a143 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7897515 |
PMID | 33615425 |
PQID | 2548930340 |
PQPubID | 36867 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7897515 proquest_miscellaneous_2492280955 proquest_journals_2548930340 pubmed_primary_33615425 crossref_citationtrail_10_1007_s00380_021_01793_3 crossref_primary_10_1007_s00380_021_01793_3 springer_journals_10_1007_s00380_021_01793_3 |
PublicationCentury | 2000 |
PublicationDate | 2021-08-01 |
PublicationDateYYYYMMDD | 2021-08-01 |
PublicationDate_xml | – month: 08 year: 2021 text: 2021-08-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Tokyo |
PublicationPlace_xml | – name: Tokyo – name: Japan |
PublicationTitle | Heart and vessels |
PublicationTitleAbbrev | Heart Vessels |
PublicationTitleAlternate | Heart Vessels |
PublicationYear | 2021 |
Publisher | Springer Japan Springer Nature B.V |
Publisher_xml | – name: Springer Japan – name: Springer Nature B.V |
References | H Baumgartner (1793_CR15) 2017; 38 J Afilalo (1793_CR12) 2017; 70 R Boxer (1793_CR32) 2010; 16 I Fauchère (1793_CR36) 2014; 173 RS Boxer (1793_CR30) 2008; 17 AK Okoh (1793_CR28) 2017; 90 MB Leon (1793_CR4) 2016; 374 RA Nishimura (1793_CR16) 2017; 135 P Kleczynski (1793_CR11) 2017; 185 E Tamuleviciute-Prasciene (1793_CR38) 2018; 2018 Z Li (1793_CR9) 2019; 9 M Ogawa (1793_CR39) 2017; 6 I Waite (1793_CR33) 2017; 12 M Ogawa (1793_CR24) 2017; 12 N Yoshida (1793_CR21) 2017; 16 M Ogawa (1793_CR10) 2019 T Teramoto (1793_CR22) 2014; 21 RA Nishimura (1793_CR14) 2014; 129 CW Yancy (1793_CR20) 2013; 128 MB Leon (1793_CR3) 2010; 363 SM O’Brien (1793_CR19) 2018; 105 N Russo (1793_CR34) 2014; 21 S Eichler (1793_CR35) 2017; 24 C Bäck (1793_CR27) 2019; 53 LP Fried (1793_CR23) 2001; 56 SV Arnold (1793_CR6) 2014; 129 A Grimaldi (1793_CR5) 2013; 168 J Mehilli (1793_CR8) 2019; 35 SAM Nashef (1793_CR17) 2012; 41 RL Mehta (1793_CR26) 2007; 11 F Tarro Genta (1793_CR37) 2017; 18 R Ofori-Asenso (1793_CR40) 2019; 2 N Hiltrop (1793_CR7) 2016; 2 S Yamada (1793_CR31) 2015; 2 B Iung (1793_CR2) 2003; 24 TR Talbot (1793_CR25) 2005; 33 DM Shahian (1793_CR18) 2018; 105 CM Otto (1793_CR13) 2017; 69 BR Lindman (1793_CR1) 2016; 2 CP Huded (1793_CR29) 2016; 117 |
References_xml | – volume: 168 start-page: 281 year: 2013 ident: 1793_CR5 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2012.09.079 – volume: 135 start-page: e1159 year: 2017 ident: 1793_CR16 publication-title: Circulation doi: 10.1161/CIR.0000000000000503 – volume: 16 start-page: 208 year: 2010 ident: 1793_CR32 publication-title: Congest Heart Fail doi: 10.1111/j.1751-7133.2010.00151.x – volume: 363 start-page: 1597 year: 2010 ident: 1793_CR3 publication-title: N Engl J Med doi: 10.1056/NEJMoa1008232 – volume: 2 start-page: 184 year: 2016 ident: 1793_CR7 publication-title: Eur Heart J Qual Care Clin Outcomes doi: 10.1093/ehjqcco/qcw001 – volume: 105 start-page: 1419 year: 2018 ident: 1793_CR19 publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2018.03.003 – volume: 16 start-page: 96 year: 2017 ident: 1793_CR21 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-017-0577-8 – volume: 41 start-page: 734 year: 2012 ident: 1793_CR17 publication-title: Eur J Cardiothorac Surg doi: 10.1093/ejcts/ezs043 – volume: 24 start-page: 257 year: 2017 ident: 1793_CR35 publication-title: Eur J Prev Cardiol doi: 10.1177/2047487316679527 – volume: 12 start-page: e0190359 year: 2017 ident: 1793_CR24 publication-title: PLoS ONE doi: 10.1371/journal.pone.0190359 – volume: 129 start-page: 2682 year: 2014 ident: 1793_CR6 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.007477 – volume: 129 start-page: e521 year: 2014 ident: 1793_CR14 publication-title: Circulation – volume: 53 start-page: 348 year: 2019 ident: 1793_CR27 publication-title: Scand Cardiovasc J doi: 10.1080/14017431.2019.1644366 – volume: 24 start-page: 1231 year: 2003 ident: 1793_CR2 publication-title: Eur Heart J doi: 10.1016/S0195-668X(03)00201-X – volume: 35 start-page: 199 year: 2019 ident: 1793_CR8 publication-title: Can J Cardiol doi: 10.1016/j.cjca.2018.11.035 – volume: 21 start-page: 296 year: 2014 ident: 1793_CR22 publication-title: J Atheroscler Thromb doi: 10.5551/jat.19737 – year: 2019 ident: 1793_CR10 publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2019.11.069 – volume: 38 start-page: 2739 year: 2017 ident: 1793_CR15 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehx391 – volume: 18 start-page: 114 year: 2017 ident: 1793_CR37 publication-title: J Cardiovasc Med (Hagerstown) doi: 10.2459/JCM.0000000000000494 – volume: 11 start-page: R31 year: 2007 ident: 1793_CR26 publication-title: Crit Care doi: 10.1186/cc5713 – volume: 185 start-page: 52 year: 2017 ident: 1793_CR11 publication-title: Am Heart J doi: 10.1016/j.ahj.2016.12.005 – volume: 21 start-page: 1341 year: 2014 ident: 1793_CR34 publication-title: Eur J Prev Cardiol doi: 10.1177/2047487313494029 – volume: 69 start-page: 1313 year: 2017 ident: 1793_CR13 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.12.006 – volume: 9 start-page: e024163 year: 2019 ident: 1793_CR9 publication-title: BMJ Open doi: 10.1136/bmjopen-2018-024163 – volume: 90 start-page: 1000 year: 2017 ident: 1793_CR28 publication-title: Catheter Cardiovasc Interv doi: 10.1002/ccd.27083 – volume: 374 start-page: 1609 year: 2016 ident: 1793_CR4 publication-title: N Engl J Med doi: 10.1056/NEJMoa1514616 – volume: 12 start-page: 91 year: 2017 ident: 1793_CR33 publication-title: J Cardiothorac Surg doi: 10.1186/s13019-017-0655-8 – volume: 6 start-page: 38 year: 2017 ident: 1793_CR39 publication-title: Res in Cardiovasc Med doi: 10.4103/rcm.rcm_22_17 – volume: 2 start-page: 16006 year: 2016 ident: 1793_CR1 publication-title: Nat Rev Dis Primers doi: 10.1038/nrdp.2016.6 – volume: 128 start-page: e240 year: 2013 ident: 1793_CR20 publication-title: Circulation – volume: 70 start-page: 689 year: 2017 ident: 1793_CR12 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2017.06.024 – volume: 117 start-page: 1966 year: 2016 ident: 1793_CR29 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2016.03.044 – volume: 105 start-page: 1411 year: 2018 ident: 1793_CR18 publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2018.03.002 – volume: 173 start-page: 564 year: 2014 ident: 1793_CR36 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2014.03.121 – volume: 2 start-page: e198398 year: 2019 ident: 1793_CR40 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2019.8398 – volume: 56 start-page: M146 issue: 3 year: 2001 ident: 1793_CR23 publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/56.3.M146 – volume: 2018 start-page: 9849475 year: 2018 ident: 1793_CR38 publication-title: Biomed Res Int doi: 10.1155/2018/9849475 – volume: 17 start-page: 7 year: 2008 ident: 1793_CR30 publication-title: Am J Geriatr Cardiol doi: 10.1111/j.1076-7460.2007.06457.x – volume: 2 start-page: 168 year: 2015 ident: 1793_CR31 publication-title: ESC Heart Fail doi: 10.1002/ehf2.12052 – volume: 33 start-page: 353 issue: 6 year: 2005 ident: 1793_CR25 publication-title: Am J Infect Control doi: 10.1016/j.ajic.2004.10.008 |
SSID | ssj0015919 |
Score | 2.3129435 |
Snippet | Assessment of frailty is important for risk stratification among the elderly with severe aortic stenosis (AS) when considering interventions such as surgical... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1234 |
SubjectTerms | Aged Aged, 80 and over Aorta Aortic stenosis Aortic valve Aortic Valve Stenosis - diagnosis Aortic Valve Stenosis - surgery Biomedical Engineering and Bioengineering Cardiac Surgery Cardiology Complications Exercise Tolerance Frailty Frailty - complications Frailty - diagnosis Heart Valve Prosthesis Implantation Heart valves Humans Medicine Medicine & Public Health Original Original Article Patient Discharge Postoperative Complications - epidemiology Recovery of function Retrospective Studies Stenosis Therapeutic applications Transcatheter Aortic Valve Replacement - adverse effects Vascular Surgery |
Title | Preoperative frailty affects postoperative complications, exercise capacity, and home discharge rates after surgical and transcatheter aortic valve replacement |
URI | https://link.springer.com/article/10.1007/s00380-021-01793-3 https://www.ncbi.nlm.nih.gov/pubmed/33615425 https://www.proquest.com/docview/2548930340 https://www.proquest.com/docview/2492280955 https://pubmed.ncbi.nlm.nih.gov/PMC7897515 |
Volume | 36 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB7aBEovpU3axmkaVCi9dA1eWw_ruCnZhJaEHrqQnowsyySQ2IvXe8iv6V_NjPwo2zSBnAzW-MWMpE-eT98AfJaFza0oeSilESF32oZpgkBuKo1SIi8kLymje3YuTxf8-4W46DeFrQa2-5CS9CP1uNmNklhRSJQCH1Vh8hy2Ba7dici3iGdj7kDoaaewhyMMxqvqt8r8_x6b09E9jHmfKvlPvtRPQ_PX8KrHj2zWOfwNPHPVDuzOKlw739yyL8wzOv2v8h14cdYnznfhz8_G1UvXyXyzsjFX1-0tMx2Zgy1JXWNs3WCZT9hQlIlZnFctgvYJM1XBLusbx2hPL0ktOUaKEyvmK46z1brx46m3a2ky9OKw1GRqenGG4Y0PapxnhNH_ybewmB__-nYa9rUZQiujtA2TQiVpriSiTc1VoQtlpTAuJ8TDNZXzQNxl8XRs47RUVsVFOTUqcaWOlUGQ9g62qrpye8BSWoPmHEOaO055yFy4qBAqcrFDNJEHMB1clNleuJzqZ1xno-Syd2uGbs28W7MkgK_jNctOtuNR64PB81nfhVcZrpwRy0UJjwL4NDZj56OMiqlcvUYbrklOSAsRwPsuUMbHJQmCRRwRA1AbITQakLD3Zkt1dekFvlWqFeLMACZDsP19rYe_Yv9p5h_gZew7ApEZD2CrbdbuIwKsNj-E7dn86Oicjie_fxwf-v51B0ZcIlA |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB7BVgIuPFoegQJGQlzYVNnEjpPjCrUstFtx6ErlFNmOo1a0ySqbPZQ_w19lxnmgbQGp13gSx_J4_I1n_A3A-zg32oiC-3GshM9tavwkQiA3iZWUQucxLyiiOz-OZwv-9VScdpfCVn22ex-SdJZ6uOxGQazAp5QCp1V-dBe2OPrgfARb08_fD_eH6IFIJy3HHtoY1FjZXZb5-1c2N6QbKPNmsuS1iKnbiA4ewaIfQpt_8mNv3eg98_Mau-Ntx_gYHnbIlE1bVXoCd2y5DTvTEr3yyyv2gblcUXcIvw335l1Ifgd-fatttbQtgTgranV-0Vwx1aaJsCXxdgytG_nrY9aXe2IGd2yD7sCYqTJnZ9WlZXRbmEicLCMuixVztczZal07S-3kGtpmHe0sNamKfpzhwsGOautyzejk8yksDvZPPs38ruqDb-Igafwol1GiZYw4NuUyT3NpYqGsJizFUyoUgojO4OPQhEkhjQzzYqJkZIs0lArh3zMYlVVpXwBLyLvVHBcLt5winFrYIBcysKFFnKI9mPRTn5mOEp0qc1xkA5mzm5AMJyRzE5JFHnwc3lm2hCD_ld7tNSrrjMMqQ58cUWIQ8cCDd0MzLmuK1ajSVmuU4SkRFaVCePC8VcChuyhCGIq21gO5oZqDAFGGb7aU52eOOlwmqUQE68G4178_v_XvUby8nfhbuD87mR9lR1-OD1_Bg9CpM6VM7sKoqdf2NcK4Rr_pVu1v_NA_IA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BVqq48GihBAoYCXFh02YTO06OK-hSKK16oFI5RbbjqBVtsspmD-XP8FeZcR6wLSAhrvHkYfmz_Tkz8w3Aqzg32oiC-3GshM9tavwkQiI3iZWUQucxL8ije3gU75_wj6fi9Jcsfhft3rsk25wGUmkqm915XuwOiW_k0Ap8Ci9wCPOj27DGSZx9BGvT918O9gZPgkgnrd4erjeIXtklzvz-Kaub0w3GeTNw8pr31G1Ks3ug-u60sShfd5aN3jHfrik9_k9_78PdjrGyaQuxB3DLlhuwOS3xtH55xV4zF0Pqfs5vwPph56rfhO_Hta3mthUWZ0Wtzi-aK6ba8BE2Jz2PoXUlrn3M-jJQzOBObvCYMGaqzNlZdWkZZRGTuJNlpHGxYK7GOVssa7eCO7uGtl8nR0tNqqIPZzih8EW1dTFo9Ef0IZzM9j6_3fe7ahC-iYOk8aNcRomWMfLblMs8zaWJhbKaOBZPqYAIMj2Dl0MTJoU0MsyLiZKRLdJQKqSFj2BUVqV9DCyhU6_mOIm45eT51MIGuZCBDS3yF-3BpIdBZjqpdKrYcZENIs9uQDIckMwNSBZ58Ga4Z94KhfzVertHV9YtGosMz-rIHoOIBx68HJpxupMPR5W2WqINT0nAKBXCg60WjMProgjpKa7BHsgVmA4GJCW-2lKenzlJcZmkEpmtB-Meiz8_68-9ePJv5i9g_fjdLPv04ejgKdwJHZopknIbRk29tM-Q3TX6eTeBfwDMI0gE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Preoperative+frailty+affects+postoperative+complications%2C+exercise+capacity%2C+and+home+discharge+rates+after+surgical+and+transcatheter+aortic+valve+replacement&rft.jtitle=Heart+and+vessels&rft.au=Komaki%2C+Kodai&rft.au=Yoshida%2C+Naofumi&rft.au=Satomi-Kobayashi%2C+Seimi&rft.au=Tsuboi%2C+Yasunori&rft.date=2021-08-01&rft.issn=0910-8327&rft.eissn=1615-2573&rft.volume=36&rft.issue=8&rft.spage=1234&rft.epage=1245&rft_id=info:doi/10.1007%2Fs00380-021-01793-3&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00380_021_01793_3 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0910-8327&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0910-8327&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0910-8327&client=summon |